$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 50,813 | 0 | 584,266 | 533.5 K to 584.3 K (+9.53 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 5.13 | 84,745 | 434,742 | 84,745 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 60,975 | 0 | 96,925 | 36 K to 96.9 K (+169.61 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 5.13 | 282,485 | 1,449,148 | 282,485 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 203,252 | 0 | 331,611 | 128.4 K to 331.6 K (+158.35 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 5.13 | 103,578 | 531,355 | 103,578 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 5.13 | 50,950 | 261,374 | 176,525 | 227.5 K to 176.5 K (-22.40 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 0.00 | 100,000 | 0 | 227,475 | 127.5 K to 227.5 K (+78.45 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 74,525 | 0 | 127,475 | 53 K to 127.5 K (+140.75 %) |
| Jan 04 2017 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.96 | 94,750 | 470,055 | 16,293,847 | 16.2 M to 16.3 M (+0.58 %) |
| Dec 30 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.85 | 94,750 | 459,917 | 16,293,847 | 16.2 M to 16.3 M (+0.58 %) |
| Dec 30 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.91 | 47,375 | 232,706 | 16,199,097 | 16.2 M to 16.2 M (+0.29 %) |
| Dec 27 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.92 | 37,900 | 186,582 | 16,151,722 | 16.1 M to 16.2 M (+0.24 %) |
| Dec 27 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.72 | 47,375 | 223,468 | 16,113,822 | 16.1 M to 16.1 M (+0.29 %) |
| Dec 23 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.51 | 189,500 | 854,835 | 16,066,447 | 15.9 M to 16.1 M (+1.19 %) |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 2.45 | 2,858 | 7,002 | 30,892 | |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 8.00 | 2,858 | 22,864 | 24,189 | 27 K to 24.2 K (-10.57 %) |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 8.00 | 2,858 | 22,864 | 27,047 | 24.2 K to 27 K (+11.82 %) |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 8.00 | 5,688 | 45,504 | 24,189 | 29.9 K to 24.2 K (-19.04 %) |
| Nov 03 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.00 | 25,000 | 175,000 | 533,453 | 558.5 K to 533.5 K (-4.48 %) |
| Oct 04 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.25 | 25,000 | 181,250 | 558,453 | 583.5 K to 558.5 K (-4.28 %) |
| Sep 22 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 3,500 | 8,575 | 34,000 | |
| Sep 22 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 8.00 | 17,000 | 136,075 | 35,950 | 53 K to 36 K (-32.11 %) |
| Sep 22 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 8.00 | 3,500 | 28,000 | 52,950 | 56.5 K to 53 K (-6.20 %) |
| Sep 22 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 8.00 | 3,500 | 28,000 | 56,450 | 53 K to 56.5 K (+6.61 %) |
| Sep 08 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.00 | 25,000 | 175,000 | 583,453 | 608.5 K to 583.5 K (-4.11 %) |
| Aug 26 2016 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | Sell | S | 6.81 | 1,100,000 | 7,491,000 | 14,139,444 | 15.2 M to 14.1 M (-7.22 %) | |
| Aug 08 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 7.00 | 25,000 | 175,000 | 608,453 | 633.5 K to 608.5 K (-3.95 %) |
| Aug 08 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 7.00 | 10,458 | 73,206 | 15,000 | 25.5 K to 15 K (-41.08 %) |
| Jul 29 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Sell | S | 7.00 | 20,916 | 146,412 | 25,458 | 46.4 K to 25.5 K (-45.10 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Option Exercise | A | 6.10 | 25,000 | 152,500 | 25,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | A | 6.10 | 35,000 | 213,500 | 35,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Grant | A | 0.00 | 8,500 | 0 | 29,877 | 21.4 K to 29.9 K (+39.76 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 6.10 | 50,000 | 305,000 | 50,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Grant | A | 0.00 | 12,500 | 0 | 633,453 | 621 K to 633.5 K (+2.01 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 7.93 | 83,333 | 660,831 | 83,333 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 0.00 | 41,667 | 0 | 128,359 | 86.7 K to 128.4 K (+48.06 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 6.10 | 75,000 | 457,500 | 75,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Grant | A | 0.00 | 25,000 | 0 | 52,950 | 28 K to 53 K (+89.45 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 6.10 | 60,000 | 366,000 | 60,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Grant | A | 0.00 | 15,000 | 0 | 46,374 | 31.4 K to 46.4 K (+47.81 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 6.10 | 60,000 | 366,000 | 60,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 52,950 | 38 K to 53 K (+39.53 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Option Exercise | A | 6.10 | 17,500 | 106,750 | 17,500 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Grant | A | 0.00 | 4,250 | 0 | 4,250 | 0 to 4.3 K |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | Redmile Group, LLC | 10% Owner | Buy | P | 7.20 | 66,300 | 477,360 | 12,956,446 | 12.9 M to 13 M (+0.51 %) |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | WHEELER CRAIG A | Director | Option Exercise | A | 6.71 | 30,000 | 201,300 | 30,000 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | LOVE TED W | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | ESSNER ROBERT | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Buy | P | 7.67 | 15,000 | 115,050 | 15,000 | 0 to 15 K |
| May 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Grant | A | 6.59 | 5,000 | 32,950 | 91,692 | 86.7 K to 91.7 K (+5.77 %) |
| Feb 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Rosenberg Ellen | General Counsel & C ... | Option Exercise | A | 5.16 | 175,000 | 903,000 | 175,000 | |
| Feb 03 2016 | FOLD | AMICUS THERAPEUTIC ... | Andrews Kurt J. | SVP, Human Resource ... | Option Exercise | A | 6.13 | 75,000 | 459,750 | 75,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | A | 9.03 | 45,000 | 406,350 | 45,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Payment of Exercise | F | 9.03 | 9,313 | 84,096 | 18,874 | 28.2 K to 18.9 K (-33.04 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | M | 0.00 | 25,000 | 0 | 28,187 | 3.2 K to 28.2 K (+784.44 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | A | 9.03 | 100,000 | 903,000 | 100,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 0.00 | 50,000 | 0 | 100,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Payment of Exercise | F | 9.03 | 18,625 | 168,184 | 37,950 | 56.6 K to 38 K (-32.92 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 0.00 | 50,000 | 0 | 56,575 | 6.6 K to 56.6 K (+760.46 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | A | 9.03 | 50,000 | 451,500 | 50,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Payment of Exercise | F | 9.03 | 9,311 | 84,078 | 21,377 | 30.7 K to 21.4 K (-30.34 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Buy | M | 0.00 | 25,000 | 0 | 30,688 | 5.7 K to 30.7 K (+439.52 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Option Exercise | A | 9.03 | 75,000 | 677,250 | 75,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | A | 11.74 | 250,000 | 2,935,000 | 250,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | A | 9.03 | 90,000 | 812,700 | 90,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Payment of Exercise | F | 10.05 | 9,313 | 93,596 | 31,374 | 40.7 K to 31.4 K (-22.89 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Barth Jay | Chief Medical Offic ... | Buy | M | 0.00 | 25,000 | 0 | 40,687 | 15.7 K to 40.7 K (+159.37 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | A | 9.03 | 90,000 | 812,700 | 90,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 0.00 | 50,000 | 0 | 0 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Payment of Exercise | F | 9.03 | 18,625 | 168,184 | 37,950 | 56.6 K to 38 K (-32.92 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 0.00 | 50,000 | 0 | 56,575 | 6.6 K to 56.6 K (+760.46 %) |
| Nov 10 2015 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | P | 10.27 | 10,000 | 102,657 | 10,000 | 0 to 10 K |
| Oct 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 6.45 | 13,193 | 85,095 | 136,807 | |
| Oct 08 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 6.45 | 13,193 | 85,095 | 96,692 | 83.5 K to 96.7 K (+15.80 %) |
| Oct 08 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.27 | 50,000 | 313,500 | 15,239,444 | 15.2 M to 15.2 M (+0.33 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.34 | 7,000 | 44,380 | 15,189,444 | 15.2 M to 15.2 M (+0.05 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 14,000 | 90,580 | 15,182,444 | 15.2 M to 15.2 M (+0.09 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.65 | 14,000 | 93,100 | 15,168,444 | 15.2 M to 15.2 M (+0.09 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.34 | 43,000 | 272,620 | 15,154,444 | 15.1 M to 15.2 M (+0.28 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 86,000 | 556,420 | 15,111 | -70,889 to 15.1 K (-121.32 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.65 | 86,000 | 571,900 | 15,025,444 | 14.9 M to 15 M (+0.58 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.76 | 35,000 | 236,600 | 14,939,444 | 14.9 M to 14.9 M (+0.23 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.85 | 35,000 | 239,750 | 14,904,444 | 14.9 M to 14.9 M (+0.24 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.76 | 215,000 | 1,453,400 | 14,869,444 | 14.7 M to 14.9 M (+1.47 %) |
| Oct 07 2015 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.85 | 215,000 | 1,472,750 | 14,654,444 | 14.4 M to 14.7 M (+1.49 %) |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 2.45 | 11,250 | 27,563 | 33,750 | |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Sell | S | 13.13 | 11,250 | 147,761 | 5,688 | 16.9 K to 5.7 K (-66.42 %) |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Buy | M | 13.13 | 11,250 | 147,761 | 16,938 | 5.7 K to 16.9 K (+197.78 %) |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 6.45 | 10,000 | 64,500 | 25,000 | |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 13.14 | 10,000 | 131,362 | 3,187 | 13.2 K to 3.2 K (-75.83 %) |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | M | 13.14 | 10,000 | 131,362 | 13,187 | 3.2 K to 13.2 K (+313.77 %) |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 7,500 | 18,375 | 67,500 | |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.52 | 2,655 | 6,691 | 46,224 | |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 3.53 | 5,081 | 17,936 | 38,259 | |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 16.78 | 15,236 | 255,634 | 56,575 | 71.8 K to 56.6 K (-21.22 %) |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 16.78 | 15,236 | 255,634 | 71,811 | 56.6 K to 71.8 K (+26.93 %) |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.81 | 417 | 1,172 | 0 | |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.16 | 12,584 | 52,349 | 0 | |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 16.78 | 13,001 | 218,206 | 156,575 | 169.6 K to 156.6 K (-7.67 %) |
| Sep 22 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 16.78 | 13,001 | 218,206 | 169,576 | 156.6 K to 169.6 K (+8.30 %) |
| Sep 16 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Chief Science Offic ... | Sell | S | 17.75 | 25,000 | 443,668 | 720,953 | 746 K to 721 K (-3.35 %) |
| Sep 16 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Sell | S | 18.08 | 2,500 | 45,200 | 5,688 | 8.2 K to 5.7 K (-30.53 %) |
| Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 16,025 | 95,509 | 103,975 | |
| Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 16.00 | 16,025 | 256,400 | 83,499 | 99.5 K to 83.5 K (-16.10 %) |
| Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 16.00 | 16,025 | 256,400 | 99,524 | 83.5 K to 99.5 K (+19.19 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 4.38 | 3,000 | 13,140 | 24,000 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 4.16 | 2,500 | 10,400 | 20,000 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 5.33 | 9,500 | 50,588 | 0 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 15.00 | 3,000 | 45,000 | 27,687 | 30.7 K to 27.7 K (-9.78 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 15.00 | 3,000 | 45,000 | 30,687 | 27.7 K to 30.7 K (+10.84 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 15.00 | 2,500 | 37,500 | 27,687 | 30.2 K to 27.7 K (-8.28 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 15.00 | 2,500 | 37,500 | 30,187 | 27.7 K to 30.2 K (+9.03 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 15.00 | 9,500 | 142,500 | 27,687 | 37.2 K to 27.7 K (-25.55 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 15.00 | 9,500 | 142,500 | 37,187 | 27.7 K to 37.2 K (+34.31 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Sell | S | 15.00 | 10,000 | 150,000 | 11,933 | 21.9 K to 11.9 K (-45.59 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Buy | M | 15.00 | 10,000 | 150,000 | 21,933 | 11.9 K to 21.9 K (+83.80 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.16 | 142,250 | 591,760 | 0 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.16 | 7,750 | 32,240 | 142,250 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.03 | 142,250 | 2,137,676 | 83,499 | 225.7 K to 83.5 K (-63.01 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 15.03 | 142,250 | 2,137,676 | 225,749 | 83.5 K to 225.7 K (+170.36 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.01 | 7,750 | 116,315 | 83,499 | 91.2 K to 83.5 K (-8.49 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 15.01 | 7,750 | 116,315 | 91,249 | 83.5 K to 91.2 K (+9.28 %) |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Sell | S | 13.87 | 6,250 | 86,689 | 1,706 | 8 K to 1.7 K (-78.56 %) |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Payment of Exercise | F | 14.10 | 4,544 | 64,070 | 7,956 | 12.5 K to 8 K (-36.35 %) |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 2.52 | 1,690 | 4,259 | 9,822 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 3.53 | 910 | 3,212 | 4,379 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Sell | S | 13.98 | 2,600 | 36,350 | 8,188 | 10.8 K to 8.2 K (-24.10 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Buy | M | 13.98 | 2,600 | 36,350 | 10,788 | 8.2 K to 10.8 K (+31.75 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 4.38 | 10,000 | 43,800 | 25,000 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 13.98 | 10,000 | 139,766 | 3,187 | 13.2 K to 3.2 K (-75.83 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | M | 13.98 | 10,000 | 139,766 | 13,187 | 3.2 K to 13.2 K (+313.77 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | M | 2.45 | 2,812 | 6,889 | 39,376 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | M | 2.52 | 3,463 | 8,727 | 28,075 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | M | 3.53 | 4,374 | 15,440 | 26,252 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Sell | S | 13.97 | 10,649 | 148,818 | 5,693 | 16.3 K to 5.7 K (-65.16 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Buy | M | 13.97 | 10,649 | 148,818 | 16,342 | 5.7 K to 16.3 K (+187.05 %) |